您的位置: 首页 > 农业专利 > 详情页

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2 AND CD3 FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES
专利权人:
BIONTECH AG
发明人:
SAHIN, UGUR,STADLER, CHRISTIANE,CELIK, LEYLA,JENDRETZKI, ARNE,TURECI, OZLEM,LE GALL, FABRICE,KREUZBERG, MARIA
申请号:
CA3034186
公开号:
CA3034186A1
申请日:
2017.09.20
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present disclosure provides binding agents comprising at least three binding domains, wherein a first binding domain binds to a T cell-specific antigen and a second binding domain and a third binding domain bind to a claudin, and methods of using these binding agents or nucleic acids encoding therefor for treating cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充